Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center

被引:0
作者
Mehra Golshan
Katya Losk
Sarah Kadish
Nancy U. Lin
Judith Hirshfield-Bartek
Linda Cutone
Yasuaki Sagara
Fatih Aydogan
Kristen Camuso
Saul N. Weingart
Craig Bunnell
机构
[1] Dana Farber Cancer Institute,Department of Surgery
[2] Dana-Farber Cancer Institute,Quality and Patient Safety
[3] Dana-Farber Cancer Institute,Medical Oncology
[4] Brigham and Women’s Hospital,Department of Surgery
来源
Breast Cancer Research and Treatment | 2014年 / 148卷
关键词
Breast cancer; Surgery; Waits and delays;
D O I
暂无
中图分类号
学科分类号
摘要
Few studies have examined care processes within providers’ and institutions’ control that expedite or delay care. The authors investigated the timeliness of breast cancer care at a comprehensive cancer center, focusing on factors influencing the time from initial consultation to first definitive surgery (FDS). The care of 1,461 women with breast cancer who underwent surgery at Dana-Farber/Brigham and Women’s Cancer Center from 2011 to 2013 was studied. The interval between consultation and FDS was calculated to identify variation in timeliness of care based on procedure, provider, and patients’ sociodemographic characteristics. Targets of 14 days for lumpectomy and mastectomy and 28 days from mastectomy with immediate reconstruction were set and used to define delay. Mean days between consultation and FDS was 21.6 (range 1–175, sd 15.8) for lumpectomy, 36.7 (5–230, 29.1) for mastectomy, and 37.5 (7–111, 16) for mastectomy with reconstruction. Patients under 40 were less likely to be delayed (OR = 0.56, 95 % CI = 0.33–0.94, p = 0.03). Patients undergoing mastectomy alone (OR = 2.64, 95 % CI = 1.80–3.89, p < 0.0001) and mastectomy with immediate reconstruction (OR = 1.34 95 % CI = 1.00–1.79, p = 0.05) were more likely to be delayed when compared to lumpectomy. Substantial variation in surgical timeliness was identified. This study provides insight into targets for improvement including better coordination with plastic surgery and streamlining pre-operative testing. Cancer centers may consider investing in efforts to measure and improve the timeliness of cancer care.
引用
收藏
页码:125 / 133
页数:8
相关论文
共 61 条
  • [1] Richards MA(1999)The influence on survival of delay in the presentation and treatment of symptomatic breast cancer Br J Cancer 79 858-864
  • [2] Smith P(2013)Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity JAMA Surg. 148 516-523
  • [3] Ramirez AJ(2008)American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures J Clin Oncol 26 3631-3637
  • [4] Fentiman IS(2010)Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment Am Surg 76 1119-1122
  • [5] Rubens RD(2011)Identifying women at risk of delayed breast cancer diagnosis Jt Comm J Qual Patient Saf. 37 568-575
  • [6] Smith EC(2013)Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study Springerplus. 2 84-9
  • [7] Ziogas A(2013)Factors associated with wait times across the breast cancer treatment pathway in Ontario Springerplus 2 1-1040
  • [8] Anton-Culver H(2002)Patient delay and stage of diagnosis among breast cancer patients in Germany—a population based study Br J Cancer 86 1034-351
  • [9] Desch CE(1994)Patient’s and doctor’s delay in primary breast cancer Acta Oncol. 33 345-455
  • [10] McNiff KK(2010)A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center J Am Coll Surg 210 449-565